从卡介苗（BCG）看新冠病毒候选疫苗。
Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
机构信息
Department of Medicine, McGill University, Montreal, Quebec, Canada.
McGill International TB Centre, Montreal, Quebec, Canada.
出版信息
J Infect Dis. 2021 Feb 3;223(2):189-191. doi: 10.1093/infdis/jiaa637.
Abstract
Developers of severe acute respiratory syndrome coronavirus 2 vaccines should consider some of the lessons from a "new" vaccine introduced in 1921, namely bacille Calmette-Guérin.
摘要
严重急性呼吸系统综合征冠状病毒 2 型疫苗的研发者应从 1921 年引入的一种“新型”疫苗（即卡介苗）中吸取部分经验教训。
相似文献
1
Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.从卡介苗（BCG）看新冠病毒候选疫苗。
J Infect Dis. 2021 Feb 3;223(2):189-191. doi: 10.1093/infdis/jiaa637.
2
Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.重新利用儿童疫苗：我们能否训练免疫系统对抗 SARS-CoV-2。
Expert Rev Vaccines. 2021 Sep;20(9):1051-1057. doi: 10.1080/14760584.2021.1960161. Epub 2021 Aug 6.
3
The BCG Vaccine for COVID-19: First Verdict and Future Directions.《COVID-19 用卡介苗疫苗：初步结论和未来方向》
Front Immunol. 2021 Mar 8;12:632478. doi: 10.3389/fimmu.2021.632478. eCollection 2021.
4
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.用于开发 SARS-CoV-2 候选疫苗的新型疫苗生产平台。
Vaccine. 2021 Jan 8;39(2):197-201. doi: 10.1016/j.vaccine.2020.11.054. Epub 2020 Nov 24.
5
COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.COVID-19 大流行：SARS-CoV-2 特异性疫苗和挑战，BCG 训练免疫的保护作用，以及临床试验。
Expert Rev Vaccines. 2021 Jul;20(7):857-880. doi: 10.1080/14760584.2021.1938550. Epub 2021 Jun 15.
6
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.用于 COVID-19 的疫苗：从核酸疫苗到作为传递载体系统的卡介苗的观点。
Microbes Infect. 2020 Nov-Dec;22(10):515-524. doi: 10.1016/j.micinf.2020.09.004. Epub 2020 Sep 19.
7
Convergence between global BCG vaccination and COVID-19 pandemic.全球卡介苗接种与 COVID-19 大流行之间的趋同。
J Med Virol. 2021 Mar;93(3):1496-1505. doi: 10.1002/jmv.26450. Epub 2020 Sep 29.
8
Immunology Lessons from the SARS-CoV-2 Pandemic.来自新冠疫情的免疫学经验教训。
Annu Rev Immunol. 2021 Apr 26;39:v-vii. doi: 10.1146/annurev-iy-39-030121-100001. Epub 2021 May 3.
9
Vaccine-induced protection in aging adults and pandemic response.疫苗诱导的老年成年人保护作用与大流行应对措施
Biochem Biophys Res Commun. 2021 Jan 29;538:218-220. doi: 10.1016/j.bbrc.2020.10.090. Epub 2020 Nov 17.
10
Could mixing COVID vaccines boost immune response?混合接种新冠疫苗能增强免疫反应吗？
Nature. 2021 Feb;590(7846):375-376. doi: 10.1038/d41586-021-00315-5.
引用本文的文献
1
Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans.气溶胶传递而非肌肉注射腺病毒载体结核疫苗可诱导人体呼吸道黏膜免疫。
JCI Insight. 2022 Feb 8;7(3):e155655. doi: 10.1172/jci.insight.155655.
2
100 years of Mycobacterium bovis bacille Calmette-Guérin.牛分枝杆菌卡介苗百年史。
Lancet Infect Dis. 2022 Jan;22(1):e2-e12. doi: 10.1016/S1473-3099(21)00403-5. Epub 2021 Sep 7.
本文引用的文献
1
Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly.激活：卡介苗疫苗接种预防老年人感染的随机临床试验。
Cell. 2020 Oct 15;183(2):315-323.e9. doi: 10.1016/j.cell.2020.08.051. Epub 2020 Sep 1.
2
Coronavirus reinfections: three questions scientists are asking.新冠病毒再次感染：科学家们正在探讨的三个问题。
Nature. 2020 Sep;585(7824):168-169. doi: 10.1038/d41586-020-02506-y.
3
Early BCG Vaccination, Hospitalizations, and Hospital Deaths: Analysis of a Secondary Outcome in 3 Randomized Trials from Guinea-Bissau.早期卡介苗接种、住院和住院死亡：来自几内亚比绍的 3 项随机试验的次要结局分析。
J Infect Dis. 2019 Jan 29;219(4):624-632. doi: 10.1093/infdis/jiy544.
4
BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity.BCG 疫苗接种通过诱导与训练有素的免疫相关的细胞因子来保护人类免受实验性病毒感染。
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5. doi: 10.1016/j.chom.2017.12.010.
5
Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.经尿道治疗非肌肉浸润性膀胱癌：系统评价和荟萃分析。
J Urol. 2017 May;197(5):1189-1199. doi: 10.1016/j.juro.2016.12.090. Epub 2016 Dec 24.
6
Tuberculosis in Newborns: The Lessons of the "Lübeck Disaster" (1929-1933).新生儿结核病：“吕贝克灾难”（1929 - 1933年）的教训
PLoS Pathog. 2016 Jan 21;12(1):e1005271. doi: 10.1371/journal.ppat.1005271. eCollection 2016 Jan.
7
Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.儿童结核病潜在的遗传性和获得性免疫缺陷。
Immunol Rev. 2015 Mar;264(1):103-20. doi: 10.1111/imr.12272.
8
Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials.BCG 疫苗预防结核病的效果：随机对照试验的系统评价。
Clin Infect Dis. 2014 Feb;58(4):470-80. doi: 10.1093/cid/cit790. Epub 2013 Dec 13.
9
Vaccines against tuberculosis: where are we and where do we need to go?结核病疫苗：我们在哪里，我们需要去哪里？
PLoS Pathog. 2012;8(5):e1002607. doi: 10.1371/journal.ppat.1002607. Epub 2012 May 10.
10
A current review of infection control for childhood tuberculosis.儿童结核病感染控制的最新综述。
Tuberculosis (Edinb). 2011 Dec;91 Suppl 1:S11-5. doi: 10.1016/j.tube.2011.10.004. Epub 2011 Nov 11.
Zotero 插件